Search research articles
Contact Us
Filters
Showing results (51-60 of 63) with videos related to
Page
of 7
Sort By:
Journal of Cancer Research and Clinical Oncology
|
January 1, 1988
Treatment of advanced renal cell cancer with recombinant interferon alpha as a single agent and in combination with medroxyprogesterone acetate. A randomized multicenter trial
F Porzsolt, D Messerer, R Hautmann, et al.
European Journal of Cancer & Clinical Oncology
|
August 1, 1986
Treatment of hairy-cell leukemia with recombinant alpha 2-interferon
Z N Berneman, G Gastl, D Gangji, et al.
Journal of Interferon Research
|
August 1, 1989
Acute effects of single doses of recombinant interferon-gamma on blood cell counts and lymphocyte subsets in patients with advanced renal cell cancer
W E Aulitzky, W Aulitzky, G Gastl, et al.
Leukemia
|
June 1, 1989
Comparison of clinical efficacy and toxicity of conventional and optimum biological response modifying doses of interferon alpha-2C in the treatment of hairy cell leukemia: a retrospective analysis of 39 patients
G Gastl, M Werter, B De Pauw, et al.
British Journal of Haematology
|
October 16, 1999
Efficacy and toxicity of IFN-alpha2b combined with cytarabine in chronic myelogenous leukaemia
M Lindauer, D Domkin, H Döhner, et al.
Acta Histochemica
|
August 12, 1999
Ligands for Viscum album agglutinin and galectin-1 in human lung cancer: is there any prognostic relevance?
P Fritz, R Seizer-Schmidt, T E Mürdter, et al.
Cytometry. Part B, Clinical Cytometry
|
April 30, 2003
Immunophenotyping is an independent factor for risk stratification in AML
R Repp, U Schaekel, G Helm, et al.
Annals of Hematology
|
June 1, 1996
Interferon alpha-2c therapy of patients with chronic myelogenous leukemia: long-term results of a multicenter phase-II study. Austrian Biological Response Modifier (BRM) Study Group
J Thaler, G Gastl, T Fluckinger, et al.
Immunobiology
|
January 1, 1996
CD4 monoclonal antibody VIT4 in human alloimmune response in vitro and in vivo
D Nachbaur, D Niederwieser, G Aichinger, et al.
Bone Marrow Transplantation
|
June 19, 1998
Chemotherapy-induced mobilization of karyotypically normal PBSC for autografting in CML
T Fischer, A Neubauer, J Mohm, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 63) with videos related to
Sort By:
Page
of 7
Journal of Cancer Research and Clinical Oncology
|
January 1, 1988
Treatment of advanced renal cell cancer with recombinant interferon alpha as a single agent and in combination with medroxyprogesterone acetate. A randomized multicenter trial
F Porzsolt, D Messerer, R Hautmann, et al.
European Journal of Cancer & Clinical Oncology
|
August 1, 1986
Treatment of hairy-cell leukemia with recombinant alpha 2-interferon
Z N Berneman, G Gastl, D Gangji, et al.
Journal of Interferon Research
|
August 1, 1989
Acute effects of single doses of recombinant interferon-gamma on blood cell counts and lymphocyte subsets in patients with advanced renal cell cancer
W E Aulitzky, W Aulitzky, G Gastl, et al.
Leukemia
|
June 1, 1989
Comparison of clinical efficacy and toxicity of conventional and optimum biological response modifying doses of interferon alpha-2C in the treatment of hairy cell leukemia: a retrospective analysis of 39 patients
G Gastl, M Werter, B De Pauw, et al.
British Journal of Haematology
|
October 16, 1999
Efficacy and toxicity of IFN-alpha2b combined with cytarabine in chronic myelogenous leukaemia
M Lindauer, D Domkin, H Döhner, et al.
Acta Histochemica
|
August 12, 1999
Ligands for Viscum album agglutinin and galectin-1 in human lung cancer: is there any prognostic relevance?
P Fritz, R Seizer-Schmidt, T E Mürdter, et al.
Cytometry. Part B, Clinical Cytometry
|
April 30, 2003
Immunophenotyping is an independent factor for risk stratification in AML
R Repp, U Schaekel, G Helm, et al.
Annals of Hematology
|
June 1, 1996
Interferon alpha-2c therapy of patients with chronic myelogenous leukemia: long-term results of a multicenter phase-II study. Austrian Biological Response Modifier (BRM) Study Group
J Thaler, G Gastl, T Fluckinger, et al.
Immunobiology
|
January 1, 1996
CD4 monoclonal antibody VIT4 in human alloimmune response in vitro and in vivo
D Nachbaur, D Niederwieser, G Aichinger, et al.
Bone Marrow Transplantation
|
June 19, 1998
Chemotherapy-induced mobilization of karyotypically normal PBSC for autografting in CML
T Fischer, A Neubauer, J Mohm, et al.
Page
of 7